The free version of ChatGPT may provide inaccurate or incomplete responses — or no answer at all — to questions related to medications, which could potentially endanger patients who use OpenAI's viral chatbot, a new study released Tuesday suggests. Pharmacists at Long Island University who posed 39 questions to the free ChatGPT in May deemed that only 10 of the chatbot's responses were "satisfactory" based on criteria they established. Notably, the free version of ChatGPT is limited to using data sets through September 2021 — meaning it could lack significant information in the rapidly changing medical landscape. Grossman acknowledged there's a chance that a paid version of ChatGPT would have produced better study results. It's possible that the free version of ChatGPT has improved and may produce better results if the researchers conducted a similar study now, she added.

---

Persons: Sara Grossman, LIU, National Institutes of Health's MedlinePlus, Grossman, ChatGPT, there's Organizations: Pharmacists, Long Island University, National Institutes of Health's, Federal Trade Commission